SeaSpine (SPNE) Stock Price, News & Analysis

Company Overview

As of January 4, 2023, SeaSpine Holdings Corporation was acquired by Orthofix Medical Inc. SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Key Stats

• Today's Range: $8.43 to $9.67
• 50-Day Range: $7.03 to $9.54
• 52-Week Range: $5.48 to $14.23
• Volume: 1.16 million shs
• Average Volume: 822,700 shs
• Market Capitalization: $354.92 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SPNE Stock Analysis - Frequently Asked Questions

How were SeaSpine's earnings last quarter?

SeaSpine Holdings Co. (NASDAQ:SPNE) released its earnings results on Thursday, October, 28th. The medical equipment provider reported ($0.48) EPS for the quarter, missing analysts' consensus estimates of ($0.31) by $0.17. The firm's revenue was up 7.5% compared to the same quarter last year.

What other stocks do shareholders of SeaSpine own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaSpine investors own include AbbVie (ABBV), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Amarin (AMRN), Alphatec (ATEC), Meta Platforms (META) and uniQure (QURE).

Company Calendar

• Last Earnings: 10/28/2021
• Today: 5/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SPNE
• CIK: 1637761
• Web: www.seaspine.com
• Phone: (760) 727-8399
• Fax: N/A
• Employees: 523
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.77)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-54,350,000.00
• Net Margins: -28.22%
• Pretax Margin: -28.83%
• Return on Equity: -22.16%
• Return on Assets: -17.09%

Debt

• Debt-to-Equity Ratio: 0.09
• Current Ratio: 3.18
• Quick Ratio: 1.65

Sales & Book Value

• Annual Sales: $191.45 million
• Price / Sales: 1.85
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $8.57 per share
• Price / Book: 1.11

Miscellaneous

• Outstanding Shares: 37,203,000
• Free Float: 33,736,000
• Market Cap: $354.92 million
• Optionable: Optionable
• Beta: 1.31